Publication
DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture
Downloadable Content
- Persistent URL
- Last modified
- 02/20/2025
- Type of Material
- Authors
-
-
Parimal Majumder, Emory UniversityJeremy Boss, Emory University
- Language
- English
- Date
- 2011-06
- Publisher
- Nature Publishing Group: Open Access Hybrid Model Option B
- Publication Version
- Copyright Statement
- © 2011 Macmillan Publishers Limited All rights reserved
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1466-4879
- Volume
- 12
- Issue
- 4
- Start Page
- 291
- End Page
- 299
- Grant/Funding Information
- National Institute of General Medical Sciences : NIGMS
- This work was supported by NIH grant GM47310.
- Supplemental Material (URL)
- Abstract
- The MHC-II locus encodes a cluster of highly polymorphic genes HLA-DR, -DQ, and -DP that are co-expressed in mature B lymphocytes. Two cell lines were established over 30 years ago from a patient diagnosed with acute lymphocytic leukemia. Laz221 represented the leukemic cells of the patient; whereas Laz388 represented the normal B cells of the patient. Whereas Laz388 expressed both HLA-DR and HLA-DQ surface and gene products, Laz221 expressed only HLA-DR genes. The discordant expression of HLA-DR and HLA-DQ genes was due to epigenetic silencing of the HLA-DQ region CTCF-binding insulators that separate the MHC-II subregions by DNA methylation. These epigenetic modifications resulted in the loss of binding of the insulator protein CTCF to the HLA-DQ flanking insulator regions and the MHC-II specific transcription factors to the HLA-DQ promoter regions. These events led to the inability of the HLA-DQ promoter regions to interact with flanking insulators that control HLA-DQ expression. Inhibition of DNA methylation by treatment with 5’deoxyazacytidine reversed each of these changes and restored expression of the HLA-DQ locus. These results highlight the consequence of disrupting an insulator within the MHC-II region and may be a normal developmental mechanism or one used by tumor cells to escape immune surveillance.
- Author Notes
- Keywords
- Research Categories
- Biology, Genetics
- Health Sciences, Immunology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - v0tkp.pdf | Primary Content | 2025-02-03 | Public | Download |